Lifestyle data is not molecular data
Steps, sleep and nutrition describe inputs and behaviours. microRNA measurements provide a different view of biological activity.
Who it’s for · Proactive individuals
You already track your health. Now preserve a view of your molecular state.
For health-conscious individuals, the opportunity is not another wellness score. It is a scientifically grounded profile that can add current insight today and a personal reference point for understanding future change.
miCheckup is the current Early Cancer Detection Test. Broader longitudinal and multi-disease applications remain miRoncol research directions.
MindsetProactive rather than symptom-driven
Starting pointHealthy and asymptomatic
Current applicationmiCheckup Early Cancer Detection Test
Longer-term valueA personal molecular history
Why add molecular information?
Most wellness tools describe behaviour. Few describe active biology.
Nutrition, fitness, sleep and wearable data are valuable, but they do not answer the same question as a measured molecular profile.
A healthy baseline is time-sensitive
The opportunity to record an asymptomatic personal state exists now; it cannot be reconstructed after a major biological change.
More data still needs interpretation
A useful result belongs within validated performance, physician guidance and the person’s broader screening plan.
How it fits into a proactive routine
Add a molecular layer without turning wellness into self-diagnosis.
The strongest use is a defined, physician-supported addition to prevention,not a replacement for established care.
Start with current eligibility
Review intended use, limitations and availability on the dedicated miCheckup website.
Use a convenient sample
The current oncology application begins with a standard blood draw and laboratory analysis.
Review with a physician
Results should be placed within medical history, recommended screening and appropriate follow-up.
Keep the broader history
With appropriate consent and governance, repeated profiles can support future longitudinal research.
What this relationship creates
Value for the individual,and a stronger foundation for preventive science.
A proactive audience does more than adopt a test. It creates the conditions in which healthy baselines, ongoing context and responsible research can become possible.
A more complete prevention conversation
Molecular information can sit alongside lifestyle, family history, routine screening and physician judgment.
Earlier, better-structured questions
A defined result and follow-up pathway can turn general concern into a more informed clinical conversation.
The healthy reference state
Consented research involving asymptomatic participants can help investigate how patterns change before and after important health events.
Use it responsibly
Proactive does not mean unbounded.
The value of earlier information depends on using it for the right person, for the right question and with clear clinical limits.
Potentially appropriate context
Healthy, informed and prepared to follow up
- You are asymptomatic and want an additional early-warning layer.
- You understand that neither result category is a diagnosis.
- You will continue every screening program recommended for you.
- You are prepared to review the result with a physician.
Seek direct medical guidance
Symptoms or complex circumstances
- Do not use screening to evaluate a new or concerning symptom.
- Pregnancy, active cancer treatment and other exclusions require review.
- A negative result cannot rule out cancer.
- Confirm complete current eligibility on miCheckup.
Choose the right next step
Start with the current test,or understand the broader platform.
miCheckup contains current cancer-test information. miRoncol explains how molecular measurement, AI and longitudinal history can grow into a broader intelligence platform.